New Key Statistics Module, Z-Score and F-Score
SZSE:301263 Key Ratios
Market Cap ¥ M | 5,305.95 |
Enterprise Value ¥ M | 4,841.73 |
P/E(ttm) | 33.70 |
PE Ratio without NRI | 31.49 |
Forward PE Ratio | -- |
Price/Book | 2.89 |
Price/Sales | 6.84 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 76.98 |
Payout Ratio % | 1.77 |
Revenue (TTM) ¥ M | 756.00 |
EPS (TTM) ¥ | 0.37 |
Beneish M-Score | -2.29 |
10-y EBITDA Growth Rate % | 8.00 |
5-y EBITDA Growth Rate % | 8.00 |
y-y EBITDA Growth Rate % | -8.90 |
EV-to-EBIT | 26.31 |
EV-to-EBITDA | 26.31 |
PEG | 3.94 |
Shares Outstanding M | 425.50 |
Net Margin (%) | 20.33 |
Operating Margin % | 24.73 |
Pre-tax Margin (%) | 23.93 |
Quick Ratio | 3.96 |
Current Ratio | 4.32 |
ROA % (ttm) | 7.07 |
ROE % (ttm) | 8.39 |
ROIC % (ttm) | 12.04 |
Dividend Yield % | 2.41 |
Altman Z-Score | 8.98 |
SZSE:301263 Number of Guru Trades
SZSE:301263 Volume of Guru Trades
Gurus Latest Trades with SZSE:301263
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301263 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guangdong Taienkang Pharmaceutical Co Ltd Insider Transactions
No Available Data